Aziyo Biologics Inc reports results for the quarter ended in March - Earnings Summary

Elutia

10/05/2023 22:02

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 49 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 54 cents per
share.
    * Revenue rose 13.5% to $13.05 million from a year ago;
analysts
expected $13.70 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 49 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aziyo Biologics Inc shares had risen by 57.0% this
quarter and
lost 44.2% so far this year.
    * The company reported a quarterly loss of $7.97 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.54          -0.49          Beat
 Dec. 31 2022      -0.69          -0.38          Beat
 Sep. 30 2022      -0.66          -0.73          Missed
 Jun. 30 2022      -0.56          -0.69          Missed